GlassScriptPhysician profile
Jacqueline Joe
NPI 1972966877
$2,876.03
in general payments reported to CMS, 2019-2025
32 companies · $483 in 2025
The $483 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $289 · 2023: $984 · 2024: $1,120 · 2025: $483.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,587.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,586.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $457.88 | 2022-2025 | Rybelsus, Ozempic, Wegovy |
| Lilly USA, LLC | $315.32 | 2022-2024 | Mounjaro, Jardiance, Zepbound |
| Amgen INC. | $284.63 | 2022-2025 | Repatha, Evenity, Otezla |
| Mannkind Corporation | $170.64 | 2023-2025 | Afrezza |
| Abbott Laboratories | $158.28 | 2022-2025 | Freestyle Libre 3 |
| Exact Sciences Corporation | $135.70 | 2023-2025 | Cologuard Collection Kit |
| Radius Health, INC. | $124.43 | 2023-2024 | Tymlos |
| Tandem Diabetes Care, INC. | $107.37 | 2023-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Abbvie INC. | $102.14 | 2023-2024 | |
| Sanofi Pasteur INC. | $92.39 | 2023-2025 | |
| Insulet Corporation | $87.47 | 2023-2025 | Omnipod |
| Inspire Medical Systems, INC. | $81.71 | 2023 | Inspire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $71.28 | 2022-2025 | Jardiance |
| Ibsa Pharma INC. | $67.86 | 2024-2025 | Tirosint, Licart, Flector |
| Sanofi-Aventis U.S. LLC | $65.24 | 2022-2023 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $64.58 | 2024-2025 | |
| Corcept Therapeutics | $57.24 | 2024 | Korlym |
| Glaxosmithkline, LLC. | $56.81 | 2023-2025 | Shingrix, Arexvy, Fluarix Quadrivalent |
| Astrazeneca Pharmaceuticals LP | $53.31 | 2024-2025 | Farxiga |
| Bayer Healthcare Pharmaceuticals INC. | $44.86 | 2024-2025 | |
| Xeris Pharmaceuticals, INC. | $39.42 | 2022-2023 | Gvoke Hypopen |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $31.40 | 2022-2024 | Trulance, Xifaxan |
| Esperion Therapeutics, INC. | $27.09 | 2022-2024 | Nexletol |
| Takeda Pharmaceuticals U.S.A., INC. | $25.78 | 2022 | |
| Alvogen INC | $24.13 | 2024 | Teriparatide |
| Kyowa Kirin, INC. | $22.20 | 2024 | Crysvita |
| Boston Scientific Corporation | $19.85 | 2024 | Watchman Flx |
| Vivus LLC | $19.36 | 2022 | |
| Verity Pharmaceuticals INC. | $18.31 | 2025 | Tlando |
| Ascendis Pharma Endocrinology INC | $17.68 | 2025 | Yorvipath |
| Amneal Pharmaceuticals LLC | $16.04 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $15.63 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacqueline Joe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.